DEEP DIVE: Standard of Care in Type 2 Diabetes Management (London)

FACE TO FACE EVENT

THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY

Location: Royal Nawaab Perivale, Hoover Building, 7 Western Ave, London UB6 8DB

---

Event Agenda

Time	Topic	Speaker
09:30-10:00	Registration, Networking and Coffee
10:00-11:00	Getting the Diagnosis Right This session covers diabetes diagnosis (HbA1c, fasting glucose, OGTT) with key pitfalls, differentiation of Type 2 from LADA, MODY, Type 1 and secondary diabetes, the role of autoantibodies, C-peptide and red flags, risk stratification and high-risk phenotypes, plus sex-specific considerations in women (PCOS, gestational diabetes, menopause) and screening for hypogonadism in men.	Prof. Saqib Mahmud
11:00-11:30	Coffee Break
11:30-12:30	Prevention, Early Intervention & Holistic Assessment This session covers preventing diabetes progression through lifestyle and pharmacological strategies, the legacy effect, comprehensive risk assessment (cardiovascular, renal, liver and microvascular), including eye disease screening and treatment, addressing health inequalities, and women’s health across the life course—including menopause-related cardio-renal-metabolic risk	Prof. Saqib Mahmud
12:30-13:30	LUNCH/ Networking
13:30-14:15	Lipid Optimisation- Management of LDL-C: Are Statins Enough? This promotional symposium has been organised and funded by Daiichi Sankyo UK Ltd where medicines will be discussed and is intended for UK HCPs only	Dr Kaushal Kansagra, GPwSI Diabetes
14:15-14:30	Event sponsors	Event Sponsors
14:30-15:00	Break
15:00-16:00	Modern Glycaemic Management This session covers individualising HbA1c targets, early combination therapy and avoiding therapeutic inertia, optimal use of metformin, SGLT2 inhibitors and GLP-1 receptor agonists, a weight-centric approach, confident insulin initiation, cardio-renal protection—particularly in women through menopause—and guideline-based management of hypogonadism in men with Type 2 diabetes.	Prof. Saqib Mahmud

Study Day Summary

Type 2 diabetes continues to drive cardiovascular, renal, and metabolic morbidity across the UK. While treatment options have expanded significantly, translating evolving NICE guidance into confident, real-world prescribing decisions can be challenging in busy primary care settings.This face-to-face study day provides a structured, practical update on modern diabetes management — from getting the diagnosis right to delivering holistic, prevention-focused care and optimising advanced therapies.Through case-based discussions and expert-led teaching, delegates will gain clarity on risk stratification, treatment intensification, and safe prescribing decisions that improve long-term patient outcomes.

Learning outcomes

By the end of this study day, participants will be able to:

• Apply current diagnostic criteria for type 2 diabetes and recognise atypical presentations.
• Stratify cardiovascular and renal risk at diagnosis to guide early treatment decisions.
• Implement prevention-focused strategies, including weight-centred and lifestyle-based interventions.
• Optimise modern pharmacotherapy, including SGLT2 inhibitors and GLP-1 receptor agonists, in line with NICE guidance.
• Confidently intensify treatment, including safe insulin initiation where appropriate.
• Deliver holistic annual reviews that move beyond QOF tick-box approaches to genuinely improve outcomes.

Key Benefits

• Practical, real-world application of national guidance
• Clear decision-making frameworks for complex multimorbidity
• Improved confidence in CVRM-focused diabetes care
• Peer discussion and networking in a collaborative learning environment
• CPD-accredited certificate for revalidation portfolios

Additional Information

• This is a face-to-face, CPD-accredited event.
• A certificate of attendance will be issued for full participation.
• Suitable for GPs, prescribing pharmacists, nurses, and wider primary care MDT members.

---

Meet the Speaker